Active	Status	Sponsor type	Region	Phase	Filter
7 Active 1 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
BI 1569912 / Boehringer Ingelheim
NCT06280235: A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine	Active, not recruiting	2	84	Europe, Japan, US, RoW	BI 1569912, Placebo	Boehringer Ingelheim	Depressive Disorder, Major	02/25	03/25
NCT06558344: A Study to Test Different Doses of BI 1569912 in People With Depression	Recruiting	2	222	Japan, US	BI 1569912, Placebo matching BI 1569912	Boehringer Ingelheim	Depressive Disorder, Major	05/25	05/25
NCT04937829: A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication	Completed	1	59	US	BI 1569912, Placebo	Boehringer Ingelheim	Depressive Disorder, Major	11/23	11/23
NCT04958252: A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated	Active, not recruiting	1	56	Japan	BI 1569912, Placebo	Boehringer Ingelheim	Healthy	10/23	10/23
NCT04978506: A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated	Completed	1	83	Europe	BI 1569912, Placebo	Boehringer Ingelheim	Healthy	07/24	07/24
NCT06367153: A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood	Completed	1	18	Europe	BI 1569912, repaglinide, midazolam, bupropion	Boehringer Ingelheim	Healthy	08/24	08/24
NCT06520553: A Study in Healthy Men to Test How BI 1569912 is Processed in the Body	Completed	1	8	Europe	BI 1569912 (C-14), BI 1569912 (C-13)	Boehringer Ingelheim	Healthy	10/24	10/24